Congestive heart failure (CHF) in dogs causes breathlessness, fluid accumulation, and exercise intolerance that significantly impairs quality of life, requiring careful medication management and quality of life assessment to guide end-of-life decisions.
CHF management is a balancing act between maintaining quality of life and acknowledging disease progression. Dogs in well-controlled CHF can maintain reasonable quality of life — sleeping comfortably, eating with interest, and enjoying brief activity periods. The welfare challenge intensifies as disease advances and fluid accumulation becomes harder to control. Breathlessness is distressing for dogs, and recognising when medication can no longer adequately control symptoms is critical for making timely euthanasia decisions. Resting respiratory rate monitoring at home gives owners early warning of decompensation and enables prompt veterinary intervention or compassionate quality of life discussions.